Improving long-term outcomes for patients with liver metastases from colorectal cancer

被引：44
作者：
Chong, G [1 ]
Cunningham, D
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Royal Marsden Hosp, Surrey, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 36期
关键词：
D O I：
10.1200/JCO.2005.04.4669
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9063 / 9066
页数：4
相关论文
共 29 条
[1]   Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases? [J].
Adam, R ;
Pascal, G ;
Castaing, D ;
Azoulay, D ;
Delvart, V ;
Paule, B ;
Levi, F ;
Bismuth, H .
ANNALS OF SURGERY, 2004, 240 (06) :1052-1064
[2]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[3]   Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: A cross sectional study [J].
Adams, AS ;
Mah, C ;
Soumerai, SB ;
Zhang, F ;
Barton, MB ;
Ross-Degnan, D .
BMC HEALTH SERVICES RESEARCH, 2003, 3 (1)
[4]   Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study [J].
Alberts, SR ;
Horvath, WL ;
Stcrnfeld, WC ;
Goldberg, RM ;
Mahoney, MR ;
Dakhil, SR ;
Levitt, R ;
Rowland, K ;
Nair, S ;
Sargent, DJ ;
Donohue, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9243-9249
[5]   The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer [J].
Chau, I ;
Allen, MJ ;
Cunningham, D ;
Norman, AR ;
Brown, G ;
Ford, HER ;
Tebbutt, N ;
Tait, D ;
Hill, M ;
Ross, PJ ;
Oates, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1420-1429
[6]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[7]   Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741 [J].
Delaunoit, T ;
Alberts, SR ;
Sargent, DJ ;
Green, E ;
Goldberg, RM ;
Krook, J ;
Fuchs, C ;
Ramanathan, RK ;
Williamson, SK ;
Morton, RF ;
Findlay, BP .
ANNALS OF ONCOLOGY, 2005, 16 (03) :425-429
[8]   Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases [J].
Elias, D ;
Baton, O ;
Sideris, L ;
Boige, V ;
Malka, D ;
Liberale, G ;
Pocard, M ;
Lasser, P .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 90 (01) :36-42
[9]   Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab [J].
Ellis, LM ;
Curley, SA ;
Grothey, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4853-4855
[10]   Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates [J].
Folprecht, G ;
Grothey, A ;
Alberts, S ;
Raab, HR ;
Köhne, CH .
ANNALS OF ONCOLOGY, 2005, 16 (08) :1311-1319
123